BLUEBIRD BIO INC (BLUE) Institutional Ownership
None of the superinvestors we track currently report BLUEBIRD BIO INC (BLUE) in their latest SEC Form 13F filings.
13F filings cover institutional equity holdings and are reported quarterly with a delay. This stock may still have insider Form 4 activity or appear in future filings.
When tracked funds report positions in BLUEBIRD BIO INC (BLUE), this page will show 13F-reported ownership trends, hedge fund exposure, portfolio concentration, historical 13F filings, and estimated holding performance.
Institutional Ownership Trend
| Portfolio quarter | Institutional holders | Total reported value | Total shares |
|---|---|---|---|
| Q3 2024 | 2 | $563,791 | 1,085,257 |
| Q2 2024 | 2 | $820,911 | 834,089 |
| Q1 2024 | 2 | $54,109 | 2,227,785 |
| Q4 2023 | 2 | $41,019 | 2,665,785 |
| Q3 2023 | 1 | $1,444 | 474,900 |
| Q2 2023 | 1 | $1,810 | 550,200 |
| Q3 2022 | 1 | $4,793 | 757,110 |
| Q2 2022 | 1 | $11,633 | 2,810,000 |
| Q1 2022 | 1 | $4,559 | 940,000 |
| Q4 2020 | 1 | $26,122 | 603,700 |
| Q3 2020 | 1 | $11,567 | 214,400 |
| Q3 2019 | 1 | $3,691 | 40,200 |
Related BLUE Institutional Insights:
- BLUE Institutional Ownership & Insiders Activity
- BLUE Institutional Ownership & 13F Activity
- BLUE Top Institutional Shareholders
- BLUE Institutional Buying Activity
- BLUE Institutional Selling Activity
- Institutional Portfolio Overlap & Shared Holdings
- BLUE Insider Trading & SEC Form 4 Activity
- Top Institutional Investor Stock Rankings